Laura Kingsley

Laura Kingsley is a highly experienced Principal Scientist in Biotherapeutics Discovery at Boehringer Ingelheim, specializing in the optimization of antibody therapeutics and leading a diverse team of scientists. Kingsley's expertise includes both computational and experimental techniques, with a focus on digital transformation in drug discovery. Additionally, as an Adjunct Faculty member at Brandeis University, Kingsley teaches courses in Structural Bioinformatics. Prior to current roles, Kingsley held significant positions at Merck and GNF, where contributions included early-stage drug discovery and program leadership across various therapeutic areas. Kingsley earned a PhD from Purdue University in Computer Aided Drug Design and a Bachelor of Science from McGill University in Immunology and Microbiology.